Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07010315

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

To develop and test liver cancer prevention educational material.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Liver Cancer Digestive System Diseases Digestive System Neoplasms Fibrosis Liver Diseases Liver Neoplasms Neoplasms Neoplasms by Site Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location status: Recruiting

Location contact

Jessica Hwang, MD, MPH

CONTACT

[email protected]

346-720-7352

Jessica Hwang, MD, MPH

PRINCIPAL_INVESTIGATOR

About this study

Primary Objectives:

  • To ensure the text for the site is understood by participants, participant comprehension will be measured qualitatively through cognitive testing. Adjustments will be made to the content, messages, and layout iteratively until interviewer notes show no large discrepancies between participant understanding and the meaning of the text.
  • To ensure the site is easy to use, usability will be measured qualitatively through usability testing. Adjustments will be made to the functionality of the patient-facing portions of the web-based tool iteratively until interviewer notes indicate that participants are able to input their risk factors and download the personal summary on their own.

Secondary Objectives:

  • To describe whether the site is acceptable to users, acceptability will be measured (as part of usability testing) with the Ottawa Acceptability Measures.
  • To describe participants' knowledge of liver cancer risk factors, knowledge will be measured (as part of usability testing) with Knowledge Questions developed for this study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 18 years old
  • Participants at the HOPE Clinic
  • Able to speak and read either English or Spanish
  • For usability testing: Able to use and navigate websites on own smart phone or study computer

Exclusion criteria

  • Has been diagnosed with liver cancer
  • Cannot provide consent or otherwise participate in research activities (e.g. vision or hearing impairment)

Treatment and study plan

Cognitive testing

Behavioral

Given by Survey and one-on one interviews

Usability Testing

Behavioral

Given by surveys and one-on-one interview.

Primary outcomes

  1. Cognitive Testing

    Time frame: Up to 1.5 hours

    Participant comprehension will be measured qualitatively through cognitive testing. In cognitive testing interviews, participants are asked to "think aloud" as they review and react to new information. Participants will be presented with the storyboard (mock-up) versions of the content and asked to describe in their own words what the information means to them. Cognitive interviews may include questions about content such as length, clarity of the language, and helpfulness of the educational material. A trained research team member will ask probing questions throughout interviews as needed. Based on patient feedback, modifications will be made iteratively to the content to ensure the content is understood and interpreted as intended. There is no post-survey for cognitive testing.

  2. Usability Testing

    Time frame: Up to 1.5 hours

    Usability will be measured qualitatively using a Usability Interview Guide. Usability will also be measured using the System Usability Scale. Acceptability will be measured with the Ottawa Acceptability Measures. Knowledge will be measured pre- and post- session using knowledge questions developed by the investigators and refined during cognitive testing.

Study contacts

Contact information is provided by the study sponsor or research team.

Jessica Hwang, MD, MPH

CONTACT

[email protected]

(346) 720-7352

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Collaborators

  • Cancer Prevention Research Institute of Texas

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Jun 8, 2025
Registry last updated
Mar 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.